• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及患者前列腺癌中ERG蛋白表达及TMRPSS2-ERG融合情况

Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.

作者信息

Abdel-Hady Ahmed, El-Hindawi Ali, Hammam Olfat, Khalil Heba, Diab Sara, El-Aziz Soulafa Abd, Badawy Mohamed, Ismail Ahmed, Helmy Noha, Kamel Nora, Anis Shady, Kholy Amr El, Osili Khalid Al, Abdel-Hady Afaf, Nour Hani, Akl Maha

机构信息

Theodor Bilharz Research Institute, Imbaba, Giza, Cairo, Egypt.

Faculty of Medicine Cairo University, Cairo, Egypt.

出版信息

Open Access Maced J Med Sci. 2017 Mar 20;5(2):147-154. doi: 10.3889/oamjms.2017.037. eCollection 2017 Apr 15.

DOI:10.3889/oamjms.2017.037
PMID:28507619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5420765/
Abstract

AIM

Prostate cancer (PCa) is the second most common cancers in men worldwide. Its incidence can be influenced by several risk factors including genetic susceptibility. Therefore the search for the expression of a certain gene (ERG) and its rearrangement could give us clues for proper identification of PCa. And the study of ERG expression and its comparison to FISH in Egyptian patients can show whether ERG immunophenotype could be used instead of FISH, as it is cheaper.

MATERIALS AND METHODS

This study was performed on 85 cases of PCa, showing 30 cases with HGPIN and 30 cases of prostatic hyperplasia. All were immunohistochemistry stained using ERG monoclonal rabbit antihuman antibody was used (clone: EP111). FISH analysis was performed in 38 biopsies of PCa cases to detect TMRPSS2-ERG rearrangement using the FISH ZytoLight TriCheck Probe (SPEC TMRPSS2-ERG).

RESULTS

ERG expression was found in 26% of PCa cases and 20% of HGPIN cases. FISH analysis showed fusion of 21 cases of PCa (out of 22 cases showing ERG immunoexpression).

CONCLUSION

Our findings emphasise that only malignant and pre-malignant cells and not benign cells from the prostate stain positive. ERG expression may offer a simpler, accurate and less costly alternative for evaluation of ERG fusion status in PCa.

摘要

目的

前列腺癌(PCa)是全球男性中第二常见的癌症。其发病率会受到包括遗传易感性在内的多种风险因素的影响。因此,寻找特定基因(ERG)的表达及其重排可为我们准确识别前列腺癌提供线索。并且对埃及患者的ERG表达及其与荧光原位杂交(FISH)的比较研究可以表明ERG免疫表型是否可因其成本较低而替代FISH使用。

材料与方法

本研究对85例前列腺癌病例进行了分析,其中30例为高级别前列腺上皮内瘤变(HGPIN),30例为前列腺增生。所有病例均使用ERG单克隆兔抗人抗体(克隆号:EP111)进行免疫组织化学染色。对38例前列腺癌活检病例进行FISH分析,使用FISH ZytoLight TriCheck探针(SPEC TMRPSS2-ERG)检测TMRPSS2-ERG重排。

结果

在26%的前列腺癌病例和20%的高级别前列腺上皮内瘤变病例中发现了ERG表达。FISH分析显示22例显示ERG免疫表达的前列腺癌病例中有21例发生融合。

结论

我们的研究结果强调,只有前列腺的恶性和癌前细胞而非良性细胞染色呈阳性。ERG表达可能为评估前列腺癌中ERG融合状态提供一种更简单、准确且成本更低的替代方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/cbd978c094b8/OAMJMS-5-147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/86f7549172b6/OAMJMS-5-147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/8386ac79318f/OAMJMS-5-147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/cbd978c094b8/OAMJMS-5-147-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/86f7549172b6/OAMJMS-5-147-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/8386ac79318f/OAMJMS-5-147-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8bc/5420765/cbd978c094b8/OAMJMS-5-147-g003.jpg

相似文献

1
Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.埃及患者前列腺癌中ERG蛋白表达及TMRPSS2-ERG融合情况
Open Access Maced J Med Sci. 2017 Mar 20;5(2):147-154. doi: 10.3889/oamjms.2017.037. eCollection 2017 Apr 15.
2
The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.TMPRSS2-ERG基因融合及ERG蛋白表达在前列腺癌活检中的预后及预测价值
Dan Med J. 2016 Dec;63(12).
3
Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.ERG 蛋白表达,前列腺癌特异性标志物,在高级别前列腺上皮内瘤变(HGPIN)中的表达:对 HGPIN 相关癌症风险分层无作用。
BJU Int. 2012 Dec;110(11 Pt B):E751-5. doi: 10.1111/j.1464-410X.2012.11557.x. Epub 2012 Oct 9.
4
ERG expression in prostate cancer biopsies with and without high-grade prostatic intraepithelial neoplasia: a study in Jordanian Arab patients.伴有和不伴有高级别前列腺上皮内瘤变的前列腺癌活检组织中ERG的表达:一项针对约旦阿拉伯患者的研究
Res Rep Urol. 2019 May 22;11:149-155. doi: 10.2147/RRU.S207843. eCollection 2019.
5
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.免疫组织化学法检测 ERG 表达可作为前列腺腺癌中 TMPRSS2-ERG 融合检测的替代方法。
Am J Surg Pathol. 2011 Jul;35(7):1014-20. doi: 10.1097/PAS.0b013e31821e8761.
6
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.ETS 基因异常在前列腺非典型筛状病变中的意义:有助于鉴别前列腺导管内癌和筛状高级别前列腺上皮内瘤。
Am J Surg Pathol. 2010 Apr;34(4):478-85. doi: 10.1097/PAS.0b013e3181d6827b.
7
ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.对于高级别前列腺上皮内瘤变患者,ERG过表达和多灶性可预测后续活检中的前列腺癌。
Urol Oncol. 2016 Mar;34(3):120.e1-7. doi: 10.1016/j.urolonc.2015.10.008. Epub 2015 Nov 14.
8
The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".新型免疫组织化学标志物 ERG 在“疑似癌的非典型腺体”前列腺活检中的诊断效用。
Am J Surg Pathol. 2011 Apr;35(4):608-14. doi: 10.1097/PAS.0b013e31820bcd2d.
9
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.TMPRSS2:ERG 基因融合可预测高级别前列腺上皮内瘤变患者后续前列腺癌的检出。
J Clin Oncol. 2014 Jan 20;32(3):206-11. doi: 10.1200/JCO.2013.49.8386. Epub 2013 Dec 2.
10
ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.ERG 重排预测高级别前列腺上皮内瘤变和淋巴结转移后的癌症诊断。
Clin Cancer Res. 2012 Aug 1;18(15):4163-72. doi: 10.1158/1078-0432.CCR-11-2449. Epub 2012 Jun 13.

引用本文的文献

1
Targeted Therapy for Cancers: From Ongoing Clinical Trials to FDA-Approved Drugs.癌症的靶向治疗:从正在进行的临床试验到 FDA 批准的药物。
Int J Mol Sci. 2023 Sep 3;24(17):13618. doi: 10.3390/ijms241713618.
2
Immunohistochemical Expression of Alpha-Methyl-Coa (AMACR) and ERG in Prostatic Adenocarcinoma and Prostatic Hyperplasia: A Comparative Study.α-甲酰基辅酶 A 消旋酶(AMACR)和 ERG 在前列腺腺癌和前列腺增生中的免疫组化表达:一项对比研究。
Asian Pac J Cancer Prev. 2023 Aug 1;24(8):2861-2868. doi: 10.31557/APJCP.2023.24.8.2861.
3
Investigation of Neural Microenvironment in Prostate Cancer in Context of Neural Density, Perineural Invasion, and Neuroendocrine Profile of Tumors.

本文引用的文献

1
TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.TMPRSS2:ERG融合基因在中国前列腺癌患者中出现的频率较低。
Tumour Biol. 2016 Sep;37(9):12397-12402. doi: 10.1007/s13277-016-5116-9. Epub 2016 Jun 20.
2
Can the Free/Total PSA Ratio Predict the Gleason Score Before Prostate Biopsy?游离/总前列腺特异性抗原比值能否在前列腺活检前预测Gleason评分?
Curr Urol. 2016 Feb;9(1):24-7. doi: 10.1159/000442846. Epub 2016 Feb 10.
3
Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.
基于神经密度、神经周围浸润及肿瘤神经内分泌特征对前列腺癌神经微环境的研究
Front Oncol. 2021 Jul 1;11:710899. doi: 10.3389/fonc.2021.710899. eCollection 2021.
4
A Review of Cancer Genetics and Genomics Studies in Africa.非洲癌症遗传学与基因组学研究综述
Front Oncol. 2021 Feb 15;10:606400. doi: 10.3389/fonc.2020.606400. eCollection 2020.
5
Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data.多聚(ADP-核糖)聚合酶抑制剂在前列腺癌中的应用:分子机制、临床前及临床数据。
Target Oncol. 2020 Dec;15(6):709-722. doi: 10.1007/s11523-020-00756-4.
伴有ERG基因重排的尤因肉瘤:一项聚焦于FUS-ERG发生率及荧光原位杂交检测EWSR1-ERG融合常见陷阱的分子研究
Genes Chromosomes Cancer. 2016 Apr;55(4):340-9. doi: 10.1002/gcc.22336. Epub 2015 Dec 22.
4
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统:格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
5
Prostate Cancer in the Arab World: A View From the Inside.阿拉伯世界的前列腺癌:内部视角
Clin Genitourin Cancer. 2015 Dec;13(6):505-11. doi: 10.1016/j.clgc.2015.05.010. Epub 2015 Jun 6.
6
ERG protein expression over time: from diagnostic biopsies to radical prostatectomy specimens in clinically localised prostate cancer.ERG蛋白表达随时间的变化:从临床局限性前列腺癌的诊断性活检到根治性前列腺切除术标本
J Clin Pathol. 2015 Oct;68(10):788-94. doi: 10.1136/jclinpath-2015-202894. Epub 2015 Jun 9.
7
Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.ERG和TMPRSS2-ERG与前列腺癌的分级、分期及预后的关联取决于它们的表达水平。
Prostate. 2015 Aug 1;75(11):1216-26. doi: 10.1002/pros.23004. Epub 2015 May 4.
8
ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications.前列腺穿刺活检中ERG的表达:潜在的诊断和预后意义
Appl Immunohistochem Mol Morphol. 2015 Aug;23(7):499-505. doi: 10.1097/PAI.0000000000000119.
9
Prevention and early detection of prostate cancer.前列腺癌的预防和早期发现。
Lancet Oncol. 2014 Oct;15(11):e484-92. doi: 10.1016/S1470-2045(14)70211-6.
10
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.全球癌症发病与死亡:GLOBOCAN 2012 数据源、方法与主要模式。
Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.